Table 2

Recovery of CDF in perfusate

ConditionCDFCDFDA
5 μM50 μM5 μM50 μM
Control91  ± 492  ± 281  ± 22-a 72  ± 42-a
Probenecid (260 μM)93  ± 288  ± 283  ± 469  ± 5
Probenecid (4 mM)91  ± 690  ± 665  ± 32-b 48  ± 22-b

Data are expressed as percentage of dose recovered as CDF at the end of the 5-min incubation at physiological temperature and pH. Data reflect CDF recovery from perfusate after CDF or CDFDA dose. Values are mean ± S.D., n = 3/group.

  • 2-ap < 0.05, comparison of CDFDA to CDF controls.

  • 2-bp < 0.05, values compared with control in relevant group.